A new research collaboration and licence agreement between Imcyse and Pfizer will seek to find treatments for rheumatoid arthritis. Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active and specific immunotherapies for the treatment of severe autoimmune diseases, will be teaming up with Pfizer for Imcyse’s Rheumatoid Arthritis (RA) programme [ ]
The post Research collaboration to seek rheumatoid arthritis treatments appeared first on Health Europa.
Friday 26 February 2021
healtheuropa - 21 days ago
Research collaboration to seek rheumatoid arthritis treatments
Latest News
